Page last updated: 2024-11-07

glyoxal bis(2-hydroxyanil)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glyoxal bis(2-hydroxyanil): structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96335
SCHEMBL ID272779
SCHEMBL ID8653626
MeSH IDM0051365

Synonyms (53)

Synonym
STL301838
2,2'-[(1e,2e)-ethane-1,2-diylidenedinitrilo]diphenol
glyoxal bis(2-hydroxyanil)
glyoxal bis(o-hydroxyanil)
phenol,2'-(ethanediylidenedinitrilo)di-
nsc-68050
1149-16-2
2,2'-(ethanediylidenedinitrilo)bisphenol
glyoxylidenebis(2-hydroxyaniline)
glyoxal bis(2-hydroxyaniline)
phenol,2'-(1,2-ethanediylidenedinitrilo)bis-
nsc68050
IDI1_030847
di(2-hydroxyphenylimino)ethane
EU-0051641
MAYBRIDGE4_000265
SR-01000640578-1
HMS1521M01
BRD-K26765365-001-01-0
6-[(e)-2-(2-hydroxyanilino)ethenyl]iminocyclohexa-2,4-dien-1-one
G0153
AKOS001723774
glyoxalbis(2-hydroxyanil)
2,2'-ethanediylidenedinitrilodiphenol
einecs 214-560-0
phenol, 2,2'-(1,2-ethanediylidenedinitrilo)bis-
unii-e2aw5xx09u
nsc 68050
phenol, 2,2'-(ethanediylidenedinitrilo)di-
e2aw5xx09u ,
CCG-51271
FT-0623013
glyoxal-bis(2-hydroxyanil)
SCHEMBL272779
DTXSID7061568
mfcd00002183
SCHEMBL8653626
glyoxalbis-(ortho-hydroxyanil)
gbha
2,2'-(ethanediylidenedinitrilo)diphenol
2-((2-[(2-hydroxyphenyl)imino]ethylidene)amino)phenol #
FZKAPSZEPRQQGK-KAVGSWPWSA-N
W-108596
glyoxal-bis-(2-hydroxyanil)
2,2'-(ethane-1,2-diylidenebis(azanylylidene))diphenol
AKOS030228311
2,2'-(1e,1'e)-ethane-1,2-diylidenebis(azan-1-yl-1-ylidene)diphenol
2-[[(2e)-2-(2-hydroxyphenyl)iminoethylidene]amino]phenol
Q27276775
2-[2-(2-hydroxyphenyl)iminoethylideneamino]phenol
D90719
BS-43846
CS-0010174
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (37.84)18.7374
1990's8 (21.62)18.2507
2000's5 (13.51)29.6817
2010's9 (24.32)24.3611
2020's1 (2.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.86 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index33.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.70%)6.00%
Case Studies1 (2.70%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]